Skip to main content

Advertisement

ADVERTISEMENT

News

News
12/20/2022
St. Louis, Dec. 20, 2022 (GLOBE NEWSWIRE)–-Stereotaxis, the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the successful treatment of patients using the latest Genesis Robotic Magnetic...
St. Louis, Dec. 20, 2022 (GLOBE NEWSWIRE)–-Stereotaxis, the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the successful treatment of patients using the latest Genesis Robotic Magnetic...
St. Louis, Dec. 20, 2022...
12/20/2022
EP Lab Digest

Advertisement

News
12/20/2022
SOPHIA ANTIPOLIS (Dec 16, 2022) --The current model for randomized clinical trials must be redesigned for the 21st century, according to the European Society of Cardiology (ESC), American Heart Association (AHA), World Heart Federation...
SOPHIA ANTIPOLIS (Dec 16, 2022) --The current model for randomized clinical trials must be redesigned for the 21st century, according to the European Society of Cardiology (ESC), American Heart Association (AHA), World Heart Federation...
SOPHIA ANTIPOLIS (Dec 16, 2022)...
12/20/2022
EP Lab Digest
News
12/20/2022
Companies initiate research agreement supporting development of new AI-ECG algorithm to help identify patients who may be at risk of cardiac amyloidosis
Companies initiate research agreement supporting development of new AI-ECG algorithm to help identify patients who may be at risk of cardiac amyloidosis
Companies initiate research...
12/20/2022
EP Lab Digest
News
12/20/2022
KYOTO, Japan, Dec. 16, 2022 /-- OMRON Healthcare Co., Ltd. will exhibit at Consumer Electronics Show (CES) 2023, the world's largest consumer tech show taking place in Las Vegas from Thursday, January 5,...
KYOTO, Japan, Dec. 16, 2022 /-- OMRON Healthcare Co., Ltd. will exhibit at Consumer Electronics Show (CES) 2023, the world's largest consumer tech show taking place in Las Vegas from Thursday, January 5,...
KYOTO, Japan, Dec. 16,...
12/20/2022
EP Lab Digest

Advertisement

News
12/16/2022
REHOVOT, Israel, Dec. 15, 2022 /-- CardiaCare, a clinical stage digital therapeutic company developing the world's first non-invasive, personalized neuromodulation wearable for atrial fibrillation treatment, announced...
REHOVOT, Israel, Dec. 15, 2022 /-- CardiaCare, a clinical stage digital therapeutic company developing the world's first non-invasive, personalized neuromodulation wearable for atrial fibrillation treatment, announced...
REHOVOT, Israel, Dec....
12/16/2022
EP Lab Digest
News
12/16/2022
Collaboration to Add Comprehensive Arrhythmia Monitoring Services Under CareXM's TouchPointCare Telemedicine Platform
Collaboration to Add Comprehensive Arrhythmia Monitoring Services Under CareXM's TouchPointCare Telemedicine Platform
Collaboration to Add...
12/16/2022
EP Lab Digest
News
12/14/2022
• Innovative approach can deliver high-fidelity cardiopulmonary exercise test results comparable to gold-standard testing with a wearable sensor during routine daily activities • Eliminates need for in-clinic testing and exhaustive physical...
• Innovative approach can deliver high-fidelity cardiopulmonary exercise test results comparable to gold-standard testing with a wearable sensor during routine daily activities • Eliminates need for in-clinic testing and exhaustive physical...
• Innovative approach can...
12/14/2022
EP Lab Digest

Advertisement

News
12/14/2022
LAKE OSWEGO, Ore., Dec. 12, 2022 /-- BIOTRONIK, a global leader in the treatment of cardiac and vascular disease is pleased to announce the first patient enrollment in BIO-CONDUCT, an FDA-approved investigational device exemption...
LAKE OSWEGO, Ore., Dec. 12, 2022 /-- BIOTRONIK, a global leader in the treatment of cardiac and vascular disease is pleased to announce the first patient enrollment in BIO-CONDUCT, an FDA-approved investigational device exemption...
LAKE OSWEGO, Ore., Dec. 12,...
12/14/2022
EP Lab Digest
News
12/14/2022
CARDIFF-BY-THE-SEA, Calif. and BOULDER, Colo., Dec. 13, 2022 /--Today, Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of-its-kind, purpose built, focal pulsed field ablation...
CARDIFF-BY-THE-SEA, Calif. and BOULDER, Colo., Dec. 13, 2022 /--Today, Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of-its-kind, purpose built, focal pulsed field ablation...
CARDIFF-BY-THE-SEA,...
12/14/2022
EP Lab Digest
News
12/14/2022
Acquisition expands the Maxwell Biomedical product and intellectual property portfolio.
Acquisition expands the Maxwell Biomedical product and intellectual property portfolio.
Acquisition expands the Maxwell...
12/14/2022
EP Lab Digest

Advertisement

Advertisement